ID25704A - Barang manufaktur - Google Patents

Barang manufaktur

Info

Publication number
ID25704A
ID25704A IDP20000331D ID20000331D ID25704A ID 25704 A ID25704 A ID 25704A ID P20000331 D IDP20000331 D ID P20000331D ID 20000331 D ID20000331 D ID 20000331D ID 25704 A ID25704 A ID 25704A
Authority
ID
Indonesia
Prior art keywords
relates
present
manufacturing items
pharmaceutical
pde5
Prior art date
Application number
IDP20000331D
Other languages
English (en)
Indonesian (id)
Inventor
Jeffrey Thomas Emmick
K M Ferguson
W E Pullman
J S Whitaker
Original Assignee
Lilly Icos Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22452153&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID25704(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Icos Llc filed Critical Lilly Icos Llc
Publication of ID25704A publication Critical patent/ID25704A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Formation And Processing Of Food Products (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Glass Compositions (AREA)
  • Enzymes And Modification Thereof (AREA)
IDP20000331D 1999-04-30 2000-04-26 Barang manufaktur ID25704A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13203699P 1999-04-30 1999-04-30

Publications (1)

Publication Number Publication Date
ID25704A true ID25704A (id) 2000-11-02

Family

ID=22452153

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP20000331D ID25704A (id) 1999-04-30 2000-04-26 Barang manufaktur

Country Status (47)

Country Link
EP (2) EP1173181B3 (https=)
JP (2) JP2000336043A (https=)
KR (2) KR100577057B1 (https=)
CN (2) CN1196487C (https=)
AT (1) ATE251908T1 (https=)
AU (3) AU3012900A (https=)
BE (1) BE1012957A5 (https=)
BR (2) BR0003046A (https=)
CA (2) CA2307101C (https=)
CH (2) CH692478A5 (https=)
CO (1) CO5170493A1 (https=)
CZ (1) CZ296534B6 (https=)
DE (3) DE20007861U1 (https=)
DK (2) DK1173181T6 (https=)
DZ (1) DZ3171A1 (https=)
EA (2) EA005416B1 (https=)
ES (2) ES2187234A1 (https=)
FI (1) FI20000976A7 (https=)
FR (1) FR2795646B1 (https=)
GB (1) GB2351663A (https=)
GR (1) GR1003575B (https=)
HK (1) HK1041204B (https=)
HR (2) HRP20000243A2 (https=)
HU (2) HUP0001632A3 (https=)
ID (1) ID25704A (https=)
IE (1) IE20000315A1 (https=)
IL (3) IL135817A0 (https=)
IT (1) ITMI20000922A1 (https=)
LT (1) LT4758B (https=)
LU (1) LU90569B1 (https=)
LV (1) LV12560B (https=)
MX (2) MXPA00003997A (https=)
NL (1) NL1015027C2 (https=)
NO (2) NO20002097L (https=)
NZ (2) NZ504163A (https=)
PE (1) PE20010071A1 (https=)
PL (2) PL339897A1 (https=)
PT (2) PT102457A (https=)
SE (1) SE0001518L (https=)
SG (1) SG98384A1 (https=)
SI (2) SI1173181T1 (https=)
SK (1) SK285415B6 (https=)
SV (1) SV2002000055A (https=)
TR (1) TR200001132A3 (https=)
UA (1) UA72248C2 (https=)
WO (1) WO2000066099A2 (https=)
ZA (2) ZA200002058B (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA004872B1 (ru) * 1999-08-03 2004-08-26 ЛИЛЛИ АЙКОС эЛ-эЛ-Си β-КАРБОЛИНОВЫЕ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ
DE10010612A1 (de) * 2000-03-03 2001-09-27 Merck Patent Gmbh Verwendung von PDE V-Inhibitoren
WO2001094347A1 (en) * 2000-06-08 2001-12-13 Lilly Icos Llc Tetracyclic diketopiperazine compounds as pdev inhibitors
EP1305313A1 (en) * 2000-08-02 2003-05-02 Lilly Icos LLC Fused heterocyclic derivatives as phosphodiesterase inhibitors
MXPA03011080A (es) * 2001-06-05 2004-07-08 Lilly Icos Llc Compuestos tetraciclicos como inhibidores de pde5.
GB0129274D0 (en) * 2001-12-06 2002-01-23 Pfizer Ltd Novel kit
US20060205733A1 (en) * 2004-08-26 2006-09-14 Encysive Pharmaceuticals Endothelin a receptor antagonists in combination with phosphodiesterase 5 inhibitors and uses thereof
US8580954B2 (en) * 2006-03-28 2013-11-12 Hospira, Inc. Formulations of low dose diclofenac and beta-cyclodextrin
US7495024B2 (en) 2006-08-07 2009-02-24 Via Pharmaceuticals, Inc. Phenylalkyl N-hydroxyureas for combating atherosclerotic plaque
DE102007028869A1 (de) 2007-06-22 2008-12-24 Ratiopharm Gmbh Verfahren zur Herstellung eines Arzneimittels enthaltend Tadalafil
DE102009033396A1 (de) 2009-07-16 2011-01-20 Ratiopharm Gmbh Wässrige Lösung und gelatinierte Zusammensetzung umfassend einen Phosphodiesterase-5-Inhibitor sowie diesbezügliche Verfahren und Verwendung
US20110136815A1 (en) 2009-12-08 2011-06-09 Horst Zerbe Solid oral film dosage forms and methods for making same
US10610528B2 (en) 2009-12-08 2020-04-07 Intelgenx Corp. Solid oral film dosage forms and methods for making same
US20110263606A1 (en) * 2010-04-26 2011-10-27 Horst Zerbe Solid oral dosage forms comprising tadalafil
WO2012107092A1 (en) 2011-02-10 2012-08-16 Synthon Bv Pharmaceutical composition comprising tadalafil and a cyclodextrin
RU2013141446A (ru) 2011-02-10 2015-03-20 Синтон Бв Фармацевтическая композиция, содержащая тадалафил и циклодекстрин
EP2672959A1 (en) 2011-02-10 2013-12-18 Synthon BV Granulated composition comprising tadalafil and a disintegrant
KR102239291B1 (ko) 2013-06-28 2021-04-14 한미약품 주식회사 타다라필 또는 이의 약학적으로 허용가능한 염을 포함하는 저작정 제제
KR20150056443A (ko) 2013-11-15 2015-05-26 한미약품 주식회사 타다라필 및 암로디핀을 포함하는 복합제제
JP2019065006A (ja) 2017-09-29 2019-04-25 ハンミ ファーマシューティカルズ カンパニー リミテッド 生産性及び均一性が改善されたタダラフィルを含む固形製剤、及びその製造方法
EP3749370B1 (de) * 2018-02-07 2025-05-07 Smawa GmbH Pharmazeutische formulierungen, verfahren zum herstellen einer pharmazeutischen formulierung sowie ein arzneimittel umfassend eine solche

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9311920D0 (en) * 1993-06-09 1993-07-28 Pfizer Ltd Therapeutic agents
GB9401090D0 (en) * 1994-01-21 1994-03-16 Glaxo Lab Sa Chemical compounds
GB9514465D0 (en) * 1995-07-14 1995-09-13 Glaxo Lab Sa Chemical compounds
GB9423911D0 (en) * 1994-11-26 1995-01-11 Pfizer Ltd Therapeutic agents
GB9511220D0 (en) * 1995-06-02 1995-07-26 Glaxo Group Ltd Solid dispersions
GB9514464D0 (en) * 1995-07-14 1995-09-13 Glaxo Lab Sa Medicaments
GB9514473D0 (en) * 1995-07-14 1995-09-13 Glaxo Lab Sa Chemical compounds
ES2175404T3 (es) 1996-05-10 2002-11-16 Icos Corp Derivados de carbolina.
EP0977756A1 (en) * 1997-04-25 2000-02-09 Pfizer Limited PYRAZOLOPYRIMIDINONES WHICH INHIBIT TYPE 5 CYCLIC GUANOSINE 3',5'-MONOPHOSPHATE PHOSPHODIESTERASE (cGMP PDE5) FOR THE TREATMENT OF SEXUAL DYSFUNCTION
AU4068599A (en) * 1998-05-20 1999-12-06 Schering Corporation Combination of phentolamine and cyclic gmp phosphodiesterase inhibitors for the treatment of sexual dysfunction
AU1025899A (en) 1998-09-16 2000-04-03 Icos Corporation Carboline derivatives as cgmp phosphodiesterase inhibitors
CA2346350C (en) * 1998-10-05 2008-01-08 Eisai Co., Ltd. Intraoral quickly disintegrating tablets
WO2000053148A2 (en) * 1999-03-08 2000-09-14 Merck & Co., Inc. Methods and compositions for treating erectile dysfunction
US6451807B1 (en) * 1999-04-30 2002-09-17 Lilly Icos, Llc. Methods of treating sexual dysfunction in an individual suffering from a retinal disease, class 1 congestive heart failure, or myocardial infarction using a PDE5 inhibitor
CA2365782A1 (en) * 1999-04-30 2000-11-09 William E. Pullman Treatment of female arousal disorder

Also Published As

Publication number Publication date
ATE251908T1 (de) 2003-11-15
CN1384746A (zh) 2002-12-11
WO2000066099A2 (en) 2000-11-09
EP1173181B1 (en) 2003-10-15
DZ3171A1 (https=) 2000-11-09
DK1173181T6 (en) 2015-04-27
NO20002097D0 (no) 2000-04-25
SE0001518L (sv) 2000-10-31
HK1041204B (en) 2004-03-05
AU3012900A (en) 2000-11-02
KR20010020779A (ko) 2001-03-15
NL1015027C2 (nl) 2001-02-14
ITMI20000922A1 (it) 2001-10-26
AU769946C (en) 2005-01-13
LU90569B1 (fr) 2002-02-27
DE60005940T3 (de) 2015-08-27
LV12560A (en) 2000-11-20
FR2795646B1 (fr) 2002-08-16
PE20010071A1 (es) 2001-03-22
CN1292264A (zh) 2001-04-25
HU0200912D0 (en) 2002-04-29
HUP0001632A3 (en) 2001-12-28
HU0001632D0 (en) 2000-06-28
CA2307101C (en) 2003-01-28
CZ296534B6 (cs) 2006-04-12
HRP20010778B1 (en) 2005-04-30
IL146098A (en) 2007-06-03
TR200001132A2 (tr) 2001-01-22
DE60005940T2 (de) 2004-07-29
LT2000035A (lt) 2000-11-27
GB2351663A (en) 2001-01-10
CO5170493A1 (es) 2002-06-27
SK15632001A3 (sk) 2002-02-05
EA200000355A2 (ru) 2000-10-30
KR20020008396A (ko) 2002-01-30
PT1173181E (pt) 2004-02-27
CA2371684A1 (en) 2000-11-09
EA005416B1 (ru) 2005-02-24
FI20000976A0 (fi) 2000-04-26
IE20000315A1 (en) 2001-03-07
DK1173181T3 (da) 2004-02-16
CZ20013879A3 (cs) 2002-04-17
TR200001132A3 (tr) 2001-01-22
EA200000355A3 (ru) 2001-02-26
BR0010181A (pt) 2003-02-25
SK285415B6 (sk) 2007-01-04
KR100577057B1 (ko) 2006-05-10
FR2795646A1 (fr) 2001-01-05
AU2004201988A1 (en) 2004-06-10
DE10021266A1 (de) 2000-11-16
NZ504163A (en) 2001-11-30
CH1173181H1 (https=) 2019-07-15
GR1003575B (el) 2001-05-14
ITMI20000922A0 (it) 2000-04-26
IL146098A0 (en) 2002-07-25
UA72248C2 (en) 2005-02-15
ES2208317T7 (es) 2015-09-15
FI20000976L (fi) 2000-10-30
HUP0200912A2 (en) 2002-08-28
PL197813B1 (pl) 2008-04-30
HK1041204A1 (en) 2002-07-05
HRP20010778A2 (en) 2002-12-31
DE20007861U1 (de) 2000-08-24
NO20002097L (no) 2001-10-26
NO20015275D0 (no) 2001-10-29
MXPA01010837A (es) 2002-11-07
JP2002543116A (ja) 2002-12-17
EP1415652A2 (en) 2004-05-06
EP1415652A3 (en) 2004-05-12
SI1173181T1 (en) 2004-04-30
ZA200002058B (en) 2000-11-02
NO322013B3 (no) 2017-11-06
CH692478A5 (de) 2002-07-15
PL339897A1 (en) 2000-11-06
PT102457A (pt) 2000-11-30
DK200000677A (da) 2000-10-31
GR20000100153A (el) 2000-12-29
DE60005940D1 (de) 2003-11-20
IL135817A0 (en) 2001-05-20
EA200101008A1 (ru) 2002-04-25
HUP0001632A2 (hu) 2001-05-28
WO2000066099A3 (en) 2001-01-18
HRP20000243A2 (en) 2001-12-31
MXPA00003997A (es) 2002-03-08
BE1012957A5 (fr) 2001-06-05
CA2307101A1 (en) 2000-10-30
HU230369B1 (hu) 2016-03-29
SV2002000055A (es) 2002-07-03
NO322013B1 (no) 2006-08-07
CN1196487C (zh) 2005-04-13
CA2371684C (en) 2007-10-23
AU769946B2 (en) 2004-02-12
GB0010199D0 (en) 2000-06-14
AU4490800A (en) 2000-11-17
BR0003046A (pt) 2002-07-23
LT4758B (lt) 2001-02-26
PL352629A1 (en) 2003-08-25
ES2208317T3 (es) 2004-06-16
EP1173181A2 (en) 2002-01-23
NO20015275L (no) 2001-12-06
ZA200108900B (en) 2003-03-26
SE0001518D0 (sv) 2000-04-26
NL1015027A1 (nl) 2000-10-31
SI20361A (sl) 2001-04-30
LV12560B (en) 2001-04-20
JP2000336043A (ja) 2000-12-05
FI20000976A7 (fi) 2000-10-30
NZ514882A (en) 2003-08-29
SG98384A1 (en) 2003-09-19
ES2187234A1 (es) 2003-05-16
HUP0200912A3 (en) 2003-07-28
EP1173181B3 (en) 2015-03-25
JP4975214B2 (ja) 2012-07-11

Similar Documents

Publication Publication Date Title
ID25704A (id) Barang manufaktur
WO2002000657A3 (en) Condensed pyrazindione derivatives
WO2001080860A3 (en) Daily treatment for erectile dysfunction using a pde5 inhibitor
GEP20094596B (en) Compositions comprising phosphodiesterase inhibitors for the treatment of sexual dysfunction